Cardiff Oncology, Inc.
CRDF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $138 | $210 | $209 | $207 |
| - Cash | $10 | $11 | $24 | $51 |
| + Debt | $1 | $1 | $1 | $2 |
| Enterprise Value | $129 | $200 | $186 | $157 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.8% | 11% | -27.8% | – |
| Gross Profit | $0 | -$11 | $0 | $0 |
| % Margin | 100% | -9,470.2% | 100% | 100% |
| EBITDA | -$11 | -$15 | -$14 | -$12 |
| % Margin | -8,970% | -12,134.7% | -12,985.3% | -8,262.3% |
| Net Income | -$11 | -$14 | -$13 | -$12 |
| % Margin | -9,381.7% | -11,523.1% | -12,324.8% | -7,806% |
| EPS Diluted | -0.17 | -0.21 | -0.28 | -0.25 |
| % Growth | 19% | 25% | -12% | – |
| Operating Cash Flow | -$11 | -$8 | -$13 | -$10 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$11 | -$8 | -$13 | -$10 |